Subscribe To
MBX Biosciences to Participate in Jefferies Healthcare Conference
CARMEL, Ind., May 24, 2023 (GLOBE NEWSWIRE) — MBX Biosciences, Inc., a clinical stage biopharmaceutical company developing Precision Endocrine Peptide™ (PEP™) therapeutics to treat an array of endocrine disorders, today announced that Kent Hawryluk, President and Chief Executive Officer, will present at the Jefferies Healthcare Conference on Thursday, June 8th, 2023, at 2:30 p.m. Eastern […] The post MBX Biosciences to Participate in Jefferies Healthcare Conference appeared first on ForexTV...
Read More
Posted: May 24 2023, 12:00
Author Name: forextv
Views: 111692